Clinical Trial Update: Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating LO2A eye drops for symptomatic improvement of dry eye in Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Due to Sjögren Syndrome

Drugs mentioned

• LO2A

Snippet

Sponsor: Ocuwize LTD | Conditions: Dry Eye Due to Sjögren's Syndrome | Phase 4 | Status: COMPLETED